Replies to post #183323 on Elite Pharmaceuticals Inc (ELTP)

[Couch]

huh and yet nobody asked a single question about another partner. Big surprise on that one. LOL

[Dante Fantasia]

You mean the P1,2,3 and NDA submission, and increasing revenues from generics and milestones are not enough to "signal the market this is for real"? All I see right now is light selling (it was brought to .305 on 200k shares). A partnership would "bring them closer to the players they want to compete with." What in your mind would be the strategic rationale for getting close and chummy with your competitors? How about a comparison between the cost of capital using LPC vs. what ELTP would have to give up in a partnership in your analysis as well.

Of course, you're beginning with the assumption that the reason behind the drop in sp was due to the LPC deal...how did you nail it to that one issue?

[Jimmy Joe]

During this CC questions were answered but people are still guessing. Nasrat provided some color without giving much of a clue
as to the direction Elite is going with regard to partnering.

Will Elite partner with BP? Or not? Maybe go it alone? Or not?

Did mention Pfizer blazing a trail for Elite with two opioid formulations.